Dive Brief:
Stoke Therapeutics on Tuesday revealed study results from a pair of small, mid-stage trials testing a medicine designed to target the underlying cause...
Sarepta Therapeutics has sold the priority review voucher the Food and Drug Administration granted upon last month’s approval of Elevidys, its gene therapy for...
BioMarin Pharmaceutical, having secured a long-awaited approval from the Food and Drug Administration, says its focus has now turned to launching its new hemophilia...
The first gene therapy for Duchenne muscular dystrophy will cost $3.2 million, its developer, biotechnology company Sarepta Therapeutics, said on Thursday.
The price makes the...
Intelligent document processing (IDP) is a technology that automates the processing of high volumes of unstructured data, including text, images, and videos. IDP offers...
Conviction level: High
Personal stake: Short positions in certain indexes and asset classes outlined on article below.
Expectations: Larger decline in SPY, defaults or liquidations of...
